Overview

Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Pilot Study Evaluating the Safety and Efficacy of a Co-Transplantation of NiCord®, a UCB-derived ex Vivo Expanded Population of Stem and Progenitor Cells with a Second, Unmanipulated CBU in Patients with Hematological Malignancies
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Gamida Cell ltd